RecruitingPhase 1ketamine

Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department

Sponsored by Lindsay Maguire, MD

NCT ID
NCT06085937
Target Enrollment
50 participants
Start Date
2024-05-01
Est. Completion
2026-04

About This Study

There is currently no readily available pharmacologic intervention for suicidal ideation, a true psychiatric emergency, in the Emergency Department (ED). Investigators aim to trial low-dose, intravenous ketamine, a drug with well-established use in treatment-resistant depression, for patients who present to the ED with suicidal ideation.

Conditions Studied

SuicideSuicidal IdeationDepression

Interventions

  • Ketamine

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Acutely Suicidality ("yes" answer to any of items 4 or 5 on C-SSRS "Suicidal Ideation" category)
* Require inpatient stabilization for SI or actions based on clinical observation and interview
* Are accepted for psychiatric stabilization at the University of Kansas Medical Center's Strawberry Hill campus
* Have a Glasgow Coma Score (GCS) of 15
* Age 18-65

Exclusion Criteria:

* Current or past history of psychosis
* Current or recent (past 4 weeks) symptoms of mania/hypomania as defined by Young Mania Rating Scale (YRMS) score of 12 or greater
* History of ketamine use disorder
* History of liver transplant
* Pregnancy or breastfeeding
* Imprisonment or inability to consent
* Positive urine drug screen or serum alcohol level
* Hypertension (SBP \> 160 or DBP \> 100 before administration of ketamine)
* Hypotension (SBP \< 90)
* Presence of acute medical condition requiring admission to medical service
* Allergy, intolerance, or previous adverse reaction to ketamine
* Patient has 8+ lifetime ketamine exposures
* The treating physician determines that the patient is not a good candidate for the study (e.g. medical condition/procedure, medication that would contradindicate ketamine treatment)

Study Locations (2)

University of Kansas Strawberry Hill Campus
Kansas City, Kansas, United States
University of Kansas Medical Center Emergency Department
Kansas City, Kansas, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Lindsay Maguire, MD
CONTACT
913-588-3580lmaguire@kumc.edu
Lucas Lemar
CONTACT
llemar@kumc.edu
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department | Huxley